ArTIcLe | beST prAcTIce | JuvédeRm voLuma
ReCommendations foR the use of
Consensus
Hervé Raspaldo, Klaus Hoffmann and Sandrine Sebban present recommendations for the use of Juvéderm VOLUMA following a round-table consensus discussion
HERVÉ RASPALDO is a facial plastic surgeon, Cannes, France; KLAUS HOFFMANN is a dermatologist in Germany; and SANDRINE SEBBAN is a doctor in Levallois-Perret, France
email:
doctor@raspaldo.fr
ABSTRACT Background: Appreciation that volume deficits influence facial aesthetic appearance has spurred volume restoration and contouring to treat facial ageing, congenital volume deficits, and HIV-associated lipoatrophy. Volumising and contouring have become fundamental to minimally-invasive multimodal approaches to facial aesthetic treatments. Juvéderm® VOLUMA™, a member of the Juvéderm family of hyaluronic acid products, is a robust, viscous, smooth, highly cohesive hyaluronic acid gel formulation intended for injection between the deep dermis and periosteum to restore volume and enhance 3D facial rejuvenation.
J
KEYWORDS hyaluronic acid, soft tissue augmentation, rejuvenation, consensus, volumisation, dermal filler, facial 3D
16 ❚
Methods: Experienced physicians and plastic surgeons reviewed the properties and uses of Juvéderm VOLUMA based on clinical study results and their collective practical experience. They provided specific guidelines for the use of Juvéderm VOLUMA.
Results: Pre- and post-treatment recommendations are similar to those for other minimally-invasive aesthetic procedures. Juvéderm VOLUMA is suitable for patients requiring volume restoration, creation, or contouring. Primary uses include the malar area, chin, jaw, and pre-jowl sulcus. Juvéderm VOLUMA is supplied with needles or cannulae to accommodate
UVéderM® VOLUMA™ (ALLergAn, Inc., Pringy, France) is a smooth-consistency, highly cohesive, viscous, fully reversible, volumising gel intended for facial volume restoration; it is ce-marked for this purpose and has been available in a number of
european countries for at least 2–3 years (depending on the country). A member of the Juvéderm family of hyaluronic acid products, Juvéderm VOLUMA shares many of the positive attributes of these products, but is a unique formulation that differs substantially in its intended uses and in the skills necessary for optimal clinical use. This article provides clinicians with the information they need to administer Juvéderm VOLUMA effectively and safely based on the consensus recommendations of a group of specialists in facial aesthetics. The participants comprised both aesthetic physicians and plastic surgeons from countries in which Juvéderm VOLUMA has been ce-marked and is
November/December 2011 |
prime-journal.com
clinician experience and preference. Clinicians should complete specific training with Juvéderm VOLUMA before undertaking treatments. Inexperienced users should confine their use to malar or chin restoration.
Conclusions: Juvéderm VOLUMA retains the reversible and resorbable properties of hyaluronic acids, offers a high level of effectiveness with long-lasting outcomes, stability at the injection site, and an excellent safety profile. It is best administered by clinicians experienced in volumising and who have received specific training in its use. It is also ideal for use in combination with botulinum toxin and hyaluronic acid.
available for use. each participant was very highly experienced in volumising procedures and in using the product for their patients.
Understanding the anatomic basis of facial ageing The use of botulinum toxin type A in aesthetic medicine has helped spur the growth of minimally-invasive procedures in facial aesthetics. Interest in and knowledge of the specific processes of ageing and their effects on appearance have expanded greatly. Similarly, what has been termed a ‘paradigm shift’ has taken place in medical approaches to facial rejuvenation, a shift that incorporates the concept of a 3D approach1–5
. The loss of volume (Figure
1) is now increasingly appreciated as a fundamental aspect of ageing that can be treated using minimally- invasive procedures and products, including multimodal approaches intended to provide a more natural, relaxed appearance by addressing muscle activity and contour.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84